RecallRadar

FDA Device recall Z-2023-2024

BD SARS-CoV-2 Reagents for BD MAX" Systems

On 2024-06-12 the FDA classified a Class II recall of BD SARS-CoV-2 Reagents for BD MAX" Systems by Becton Dickinson And, citing assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2023-2024
ClassificationClass II
Statusongoing
Initiated2024-05-07
Published2024-06-12
Last updated2026-09-13 11:57 UTC
CompanyBecton Dickinson And
DistributionUS

Product

BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.

Reason

Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.

Identifiers

code_info
Catalog No. 445003-01; UDI-DI: (01) 60382904450030 (17) 240803 (10) 3291356 (20) 01 (30) 1, (01) 60382904450030 (17)…Catalog No. 445003-01; UDI-DI: (01) 60382904450030 (17) 240803 (10) 3291356 (20) 01 (30) 1, (01) 60382904450030 (17) 241119 (10) 3291358 (20) 01 (30) 1, (01) 60382904450030 (17) 241217 (10) 3326001 (20) 01 (30) 1; Lot No. 3291356 (Exp. 8/3/24), 3291358 (Exp. 11/19/24), 3326001 (Exp. 12/17/24).

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2023-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.